TDC
VYNT

Thompson Davis & Co’s Vyant Bio, Inc. Common Stock VYNT Stock Holding History

Thompson Davis & Co’s Portfolio VYNT Stock Details VYNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$1K Hold
3
– – ﹤0.01% 700
2018
Q2 		$0 Hold
3
– – ﹤0.01% 768
2018
Q1 		$1K Hold
3
– – ﹤0.01% 611
2017
Q4 		$1K Sell
3
-310
-99% -$118K ﹤0.01% 649
2017
Q3 		$127K Sell
313
-429
-58% -$224K 0.22% 101
2017
Q2 		$440K Buy
742
+729
+5,608% +$426K 0.71% 31
2017
Q1 		$8K Buy
+13
New +$4.63K 0.01% 782

Other funds holding VYNT

PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
FCM
Fairbanks Capital Management Rancho Santa Fe, California $169M AUM 12.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
DM
Diker Management New York $130M AUM 97.77% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Thompson Davis & Co's VYNT Position: Q3 2018 in Review

Thompson Davis & Co held its Vyant Bio, Inc. Common Stock (VYNT) position steady in Q3 2018 at 3 shares worth $1K. The position accounts for ﹤0.01% of the portfolio, ranked #700.

Thompson Davis & Co first reported a position in VYNT in Q1 2017 and has held it in 7 quarters since. The position peaked at $440K in Q2 2017. 26 funds tracked by Wall St. Rank hold VYNT as of Q3 2018.

  • Thompson Davis & Co held 3 shares of Vyant Bio, Inc. Common Stock worth $1K as of Q3 2018.
  • Thompson Davis & Co left its Vyant Bio, Inc. Common Stock share count unchanged in Q3 2018.
  • Vyant Bio, Inc. Common Stock made up ﹤0.01% of Thompson Davis & Co's portfolio in Q3 2018, its #700 holding.
  • Thompson Davis & Co first reported a position in Vyant Bio, Inc. Common Stock in Q1 2017 and has held it in 7 quarters since.
  • Thompson Davis & Co's Vyant Bio, Inc. Common Stock position peaked at $440K in Q2 2017.
  • 26 funds tracked by Wall St. Rank held Vyant Bio, Inc. Common Stock as of Q3 2018.

Based on Thompson Davis & Co's 13F filing for Q3 2018, filed 14 Nov 2018.